SIBN vs OSIS vs SAIC vs XTNT

For growth investors, Xtant Medical Holdings, Inc.

(XTNT) is the stronger pick with 28. 4% revenue growth year-over-year, versus -2. 9% for Science Applications International Corporation (SAIC). Science Applications International Corporation (SAIC) offers the better valuation at 12. 2x trailing P/E (9. 3x forward), making it the more compelling value choice. Analysts rate SI-BONE, Inc. (SIBN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Science Applications International Corporation (SAIC) is the cheapest at 12.

2x versus OSI Systems, Inc. at 27. 7x. On forward P/E, Science Applications International Corporation is actually cheaper at 9. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Science Applications International Corporation wins at 0. 56x versus OSI Systems, Inc. 's 1. 39x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, OSI Systems, Inc.

(OSIS) delivered a total return of +149. 9%, compared to -66. 1% for Xtant Medical Holdings, Inc. (XTNT). Over 10 years, the gap is even starker: OSIS returned +372. 9% versus XTNT's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Science Applications International Corporation (SAIC) is the lower-risk stock at 0.

26β versus OSI Systems, Inc. 's 1. 44β — meaning OSIS is approximately 445% more volatile than SAIC relative to the S&P 500. On balance sheet safety, SI-BONE, Inc. (SIBN) carries a lower debt/equity ratio of 1% versus 82% for Xtant Medical Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Xtant Medical Holdings, Inc.

(XTNT) is pulling ahead at 28. 4% versus -2. 9% for Science Applications International Corporation (SAIC). On earnings-per-share growth, the picture is similar: SI-BONE, Inc. grew EPS 41. 3% year-over-year, compared to 7. 4% for Science Applications International Corporation. Over a 3-year CAGR, XTNT leads at 28. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

OSI Systems, Inc.

(OSIS) is the more profitable company, earning 8. 7% net margin versus -14. 0% for Xtant Medical Holdings, Inc. — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSIS leads at 12. 7% versus -11. 1% for SIBN. At the gross margin level — before operating expenses — SIBN leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Science Applications International Corporation (SAIC) is the more undervalued stock at a PEG of 0. 56x versus OSI Systems, Inc. 's 1. 39x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Science Applications International Corporation (SAIC) trades at 9. 3x forward P/E versus 23. 0x for OSI Systems, Inc. — 13. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SIBN: 95. 0% to $25. 25.

In this comparison, SAIC (1.

6% yield) pays a dividend. SIBN, OSIS, XTNT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Science Applications International Corporation (SAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

26), 1. 6% yield, +104. 4% 10Y return). Both have compounded well over 10 years (SAIC: +104. 4%, OSIS: +372. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SIBN (Healthcare) and OSIS (Technology) and SAIC (Technology) and XTNT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SIBN is a small-cap high-growth stock; OSIS is a small-cap quality compounder stock; SAIC is a small-cap deep-value stock; XTNT is a small-cap high-growth stock. SAIC pays a dividend while SIBN, OSIS, XTNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.